See also this year's filing and all EDGAR filings for this company.
PDF Report 0001178711_2023_Paratek_Pharmaceuticals_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001178711')"} |
Graph
Absolute values for 0001178711, Paratek Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 136,842,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 829,000 |
| 2 | PropertyPlantAndEquipmentNet | 616,000 |
| 3 | remainder_Assets | 34,251,000 |
| 4 | LiabilitiesCurrent | 37,388,000 |
| 5 | LiabilitiesNoncurrent | 260,867,000 |
| 6 | remainder_Liabilities | 45,325,000 |
| 7 | CostOfGoodsAndServicesSold | 23,056,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 145,598,000 |
| 9 | ResearchAndDevelopmentExpense | 37,823,000 |
| 10 | remainder_Expenses | 18,176,000 |
| 11 | remainder_Revenues | 160,268,000 |
| 12 | remainder_NetIncome | 819,000 |
| 13 | remainder_ComprehensiveNetIncome | 9,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 172,538,000 |
| 1 | Liabilities | 343,580,000 |
| 2 | Expenses | 224,653,000 |
| 3 | Revenues | 160,268,000 |
| 4 | StockholdersEquity | -171,042,000 |
| 5 | NetIncome | -63,566,000 |
| 6 | ComprehensiveNetIncome | -63,561,500 |
| 7 | BaseVar | 450,933,500 |
| 8 | EconomicCapitalRatio | -1.39 |